We are resolute in our commitment to help those living with and affected by the realities of neurologic diseases. We strive to preserve personhood in the face of unrelenting challenges. We stand with patients, their families and healthcare providers to navigate neuroscience’s unchartered frontiers and inevitable setbacks to deliver science that will make a meaningful difference and a remarkable impact on people’s lives.
Living with a Neurologic Disease
At AbbVie, we invest in neuroscience research that identifies opportunities to help people who live with neurologic disorders. We are advancing research and providing treatments across many neurologic disorders, including Alzheimer’s disease, bipolar disorder, bipolar depression, major depressive disorder, migraine, Parkinson’s disease, post-stroke spasticity, schizophrenia, stroke and other central nervous system disorders.
We are committed to investing in research that identifies opportunities for real modification, delivering pioneering science, built on inevitable setbacks, that will make a meaningful difference for patients.
Learn more about how we are empowering people living with migraine.
